$NDEV Novus Cannabis Medplan Unveils Game-Changing Platform

New Post Public Reply Private Reply Replies (0) Message Board
louied91
116
$NDEV Novus Cannabis Medplan Unveils Game-Changing Platform for Direct Consumer Access and Cost-Free Solutions for Cannabis Businesses

https://www.otcmarkets.com/stock/NDEV/news/No...?id=466668

Novus Acquisition & Development Corp, operating as Novus Cannabis MedPlan (OTC: NDEV), is a leading national carrier of supplemental health insurance plans and a pioneer in incorporating cannabis coverage for recreational and medicinal users. Proudly announces the launch of its innovative direct-to-consumer (D2C) and policyholder platform for cannabis businesses at no cost.



Ancillary cannabis businesses, such as Novus, provide a niche opportunity, even in the absence of federal legalization. Investors should research the compliance of health insurance and healthcare plans that offer cannabis coverage as a compliant form of cannabis distribution without handling the plant directly.



This innovative platform makes cannabis access easier for medical and recreational users through a comprehensive mobile app and computer interface. Unlike competing platforms that charge over $1,000 monthly, cannabis businesses receive this service for free. This approach promotes growth and enables seamless transactions.



The Novus platform offers a multitude of benefits for Novus Providers, including:

Exclusive Customer Acquisition: Novus has a dedicated team of 2,500 agents nationwide who focus on driving customers to purchase policies and direct that traffic to cannabis businesses, ensuring a steady influx of new clientele.

Competitive Advantage: Exclusive access to territory enables cannabis businesses and brands to differentiate themselves from competitors and capture a larger market share.

Flexible Reimbursement Options: Benefit from various reimbursement options tailored to cannabis business needs as an additional revenue stream.

Seamless Integration: The platform seamlessly integrates with existing workflows, supporting inventory control triggers and delivery options without disrupting daily operations.

Revenue Optimization: Novus generates revenue solely from policy premiums, enabling cannabis businesses to retain 100% of their sales revenue.

Advanced Inventory Management: The integrated Inventory Control feature allows dispensaries to set minimum quantity triggers for products. Automated notifications alert staff when the stock falls below these thresholds, ensuring timely reordering and preventing stockouts.

Streamlined Delivery Management: For businesses offering delivery services, the Deliveries tab simplifies consumer transfers, integrates with inventory control, and provides detailed delivery logs for enhanced tracking and accountability.

Novus Cannabis MedPlan is committed to empowering the cannabis industry with cutting-edge technology and comprehensive support. By connecting consumers and policyholders with dispensaries or brands and providing businesses with the free tools they need to succeed, Novus is shaping the future of cannabis commerce.



Conclusion

The Novus D2C and policyholder platform significantly advance the cannabis industry. It offers unparalleled consumer and business benefits. By providing free access to this powerful platform, Novus Cannabis MedPlan demonstrates its commitment to fostering growth and innovation within the cannabis sector.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Growth Outlook for the Packaging Robots Market to 2032

Updated Category News Views 128

The Expanding Landscape of Packaging Robots The Packaging Robots Market is on an exciting trajectory, projected to soar from an estimated USD 6.02 billion in 2023 to an impressive USD 16.67 billion by 2032. This remarkable growth is fueled by continuous technological advancements and the ever-increasing demand for automation, as businesses strive for greater efficiency in...

Continue Reading
Analyzing the Short Interest Trends for AutoZone Inc

Updated Category News Views 88

Understanding AutoZone Inc's Short Interest AutoZone Inc (NYSE: AZO) has recently seen a noteworthy rise in its short interest, which now stands at approximately 5.91% higher than its previous report. This increase translates to around 317 thousand shares being sold short, representing 2.15% of the total regular shares available for trading. Given its trading patterns, it...

Continue Reading
Join the Fight: Investors Urged to Act Against Flywire's Missteps

Updated Category News Views 180

Critical Insights into Flywire Corporation's Recent Challenges In light of recent events, investors in Flywire Corporation (NASDAQ: FLYW) are presented with a pivotal opportunity to address potential securities fraud claims. Allegations suggest that the company might have communicated misleading business information to the public, raising concerns among its shareholders....

Continue Reading
LEPAS L8: A Game-Changer for Electric Vehicle Enthusiasts

Updated Category News Views 308

LEPAS L8: Redefining the Future of NEVs The innovative leap forward in the world of electric vehicles comes with Chery Group's brand new energy vehicle (NEV) brand, LEPAS, and its latest offering, the L8 model. The introduction of the L8 marks a significant milestone for Chery as it establishes a new standard in driving sophistication. This model is poised to make waves...

Continue Reading
Integra LifeSciences Launches Pediatric Registry for AERA System

Updated Category News Views 128

Integra LifeSciences Initiates Pediatric AERA Registry Integra LifeSciences Holding Corporation (Nasdaq: IART), a premier global leader in medical technology, has taken a significant step forward by enrolling the first patient in the Acclarent AERA Pediatric Registry. This multi-center observational registry aims to evaluate the real-world applications of the AERA...

Continue Reading